Sanara MedTech Inc. SMTI
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 83.86% | 72.30% | 26.00% | 15.34% | -51.36% |
| Total Depreciation and Amortization | -29.82% | -37.05% | -41.40% | -64.45% | -37.92% |
| Total Amortization of Deferred Charges | -8.66% | -17.01% | -1.53% | 25.31% | 127.52% |
| Total Other Non-Cash Items | -15.13% | 6.74% | 57.99% | 111.62% | 301.46% |
| Change in Net Operating Assets | -1,360.45% | -233.92% | -43.40% | 28.51% | 114.09% |
| Cash from Operations | -3.55% | 1,067.48% | 19,470.59% | 188.52% | 230.71% |
| Capital Expenditure | 96.32% | -1.33% | -1,632.01% | -1,791.60% | -920.99% |
| Sale of Property, Plant, and Equipment | -100.00% | -100.00% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 80.45% | 54.35% | -25.62% | 9.55% | -- |
| Cash from Investing | 84.01% | 45.27% | -74.74% | -41.34% | -51.53% |
| Total Debt Issued | -100.00% | -100.00% | -58.25% | -58.25% | 15.44% |
| Total Debt Repaid | -- | -- | -- | 100.00% | 100.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 88.51% | -53.42% | -16.41% | -261.91% | -524.54% |
| Cash from Financing | -102.38% | -109.33% | -44.36% | -54.72% | 72.75% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -95.55% | -128.41% | -74.66% | -93.21% | 11,895.89% |